Definitive Healthcare named a 2025 Best Places to Work in Boston by Built InFRAMINGHAM, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of Built In’s 100 Best Places to Work in Boston, MA for 2025. The annual awards program includes companies of all sizes, from startups to large enterprises, and honors both remote-first employers as well as companies in large tech markets across the U.S.
Definitive Healthcare to Present at the 27th Annual Needham Growth ConferenceFRAMINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and its Chief Financial Officer, Rick Booth, will present at the 27th Annual Needham Growth Conference.
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization
Definitive Healthcare Announces Timing of Its Third Quarter 2024 Financial Results Conference Call and WebcastFRAMINGHAM, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2024, on Thursday, November 7, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.
Definitive Healthcare launches predictive analytics solution that empowers healthcare organizations to prepare and plan for future market conditionsMarket Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (
NASDAQDH) investors concerning the Company’s possible violations of federal securities laws.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (
NASDAQDH) investors concerning the Company’s possible violations of the federal securities laws.
Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceFRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Financial Officer, Rick Booth, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference.
The Law Offices of Frank R. Cruz Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (
NASDAQDH) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansionPopulation Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights
Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and WebcastFRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2024, on Monday, August 5, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.
Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligenceDH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare’s Board of Directors (the “Board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“PSUs”) and 1,170,047 time-based restricted stock units (“RSUs”) to Kevin Coop, Definitive Healthcare’s new Chief Executive Officer and member of the Board, effective June 24, 2024. The awards were granted as an inducement material to Mr. Coop’s commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year AwardEmpowering healthcare and life science organizations with faster insights through seamless data sharing
Definitive Healthcare Publishes 2023 Sustainability ReportSecond annual report showcases Definitive Healthcare’s continued successes related to culture, governance, and the environment
Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight ConferenceFRAMINGHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the Stifel 2024 Cross Sector Insight Conference.
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications ConferenceFRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the J.P. Morgan Global Technology, Media and Communications Conference.
Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and WebcastFRAMINGHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2024, on Tuesday, May 7, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.
Definitive Healthcare introduces Carevoyance sales enablement solution for medtech industryMedtech commercial teams can now solve frontline sales challenges with exceptional data and streamlined workflows
Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business JournalFRAMINGHAM, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of the Boston Business Journal’s Middle Market Leaders for 2024, a ranking of the 50 highest growth companies in Massachusetts. This marks the second year in a row that Definitive Healthcare has won this award.
